Literature DB >> 20178109

Complex display of putative tumor stem cell markers in the NCI60 tumor cell line panel.

Christina H Stuelten1, Susan D Mertins, Johanna I Busch, Meghan Gowens, Dominic A Scudiero, Mark W Burkett, Karen M Hite, Mike Alley, Melinda Hollingshead, Robert H Shoemaker, John E Niederhuber.   

Abstract

Tumor stem cells or cancer initiating cells (CICs) are single tumor cells that can regenerate a tumor or a metastasis. The identification and isolation of CICs remain challenging, and a variety of putative CIC markers have been described. We hypothesized that cell lines of the NCI60 panel contain CICs and express putative CIC markers. We investigated expression of putative CIC surface markers (CD15, CD24, CD44, CD133, CD166, CD326, PgP) and the activity of aldehyde dehydrogenase in the NCI60 panel singly and in combination by six-color fluorescence-activated cell sorting analysis. All investigated markers were expressed in cell lines of the NCI60 panel. Expression levels of individual markers varied widely across the 60 cell lines, and neither single marker expression nor simple combinations nor co-expression patterns correlated with the colony-formation capacity of cell lines. Rather, marker expression patterns correlated with tumor types in multidimensional analysis. Whereas some expression patterns correlated with tumor entities such as basal breast cancer, other expression patterns occurred across different tumor types and largely related to expression of a more mesenchymal phenotype in individual breast, lung, renal, and melanoma cell lines. Our data for the first time demonstrate that tumor cell lines display CIC markers in a complex pattern that relates to the tumor type. The complexity and tumor type specificity of marker display creates challenges for the application of cell sorting and other approaches to isolation of putative tumor stem cell populations and suggests that therapeutic targeting strategies will need to take this into account.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20178109      PMCID: PMC7444750          DOI: 10.1002/stem.324

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  40 in total

1.  Systematic variation in gene expression patterns in human cancer cell lines.

Authors:  D T Ross; U Scherf; M B Eisen; C M Perou; C Rees; P Spellman; V Iyer; S S Jeffrey; M Van de Rijn; M Waltham; A Pergamenschikov; J C Lee; D Lashkari; D Shalon; T G Myers; J N Weinstein; D Botstein; P O Brown
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

2.  Morphometric and colorimetric analyses of human tumor cell line growth and drug sensitivity in soft agar culture.

Authors:  M C Alley; C M Pacula-Cox; M L Hursey; L R Rubinstein; M R Boyd
Journal:  Cancer Res       Date:  1991-02-15       Impact factor: 12.701

3.  Prospective identification of tumorigenic prostate cancer stem cells.

Authors:  Anne T Collins; Paul A Berry; Catherine Hyde; Michael J Stower; Norman J Maitland
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

4.  Identification and isolation of candidate human colonic clonogenic cells based on cell surface integrin expression.

Authors:  Koji Fujimoto; R Daniel Beauchamp; Robert H Whitehead
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

Review 5.  Aldehyde dehydrogenase as a marker for stem cells.

Authors:  Jan S Moreb
Journal:  Curr Stem Cell Res Ther       Date:  2008-12       Impact factor: 3.828

6.  Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study.

Authors:  S Nakamori; M Kameyama; S Imaoka; H Furukawa; O Ishikawa; Y Sasaki; T Kabuto; T Iwanaga; Y Matsushita; T Irimura
Journal:  Cancer Res       Date:  1993-08-01       Impact factor: 12.701

7.  Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells.

Authors:  Lilly Y W Bourguignon; Karine Peyrollier; Weiliang Xia; Eli Gilad
Journal:  J Biol Chem       Date:  2008-04-25       Impact factor: 5.157

Review 8.  Side population cells in human cancers.

Authors:  Colleen Wu; Benjamin A Alman
Journal:  Cancer Lett       Date:  2008-05-19       Impact factor: 8.679

9.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

10.  Neural precursor cell chain migration and division are regulated through different beta1 integrins.

Authors:  T S Jacques; J B Relvas; S Nishimura; R Pytela; G M Edwards; C H Streuli; C ffrench-Constant
Journal:  Development       Date:  1998-08       Impact factor: 6.868

View more
  49 in total

1.  Cancer cells cyclically lose and regain drug-resistant highly tumorigenic features characteristic of a cancer stem-like phenotype.

Authors:  Kaijie He; Tong Xu; Amir Goldkorn
Journal:  Mol Cancer Ther       Date:  2011-04-25       Impact factor: 6.261

2.  LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma.

Authors:  Wenjin Liu; Kimberly B Monahan; Adam D Pfefferle; Takeshi Shimamura; Jessica Sorrentino; Keefe T Chan; David W Roadcap; David W Ollila; Nancy E Thomas; Diego H Castrillon; C Ryan Miller; Charles M Perou; Kwok-Kin Wong; James E Bear; Norman E Sharpless
Journal:  Cancer Cell       Date:  2012-06-12       Impact factor: 31.743

Review 3.  Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Aspects Med       Date:  2013-08-29

4.  Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.

Authors:  Ke-li Chen; Feng Pan; Heng Jiang; Jian-fang Chen; Li Pei; Fang-wei Xie; Hou-jie Liang
Journal:  Clin Exp Metastasis       Date:  2011-07-13       Impact factor: 5.150

5.  Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas.

Authors:  Emma Sandén; Cecilia Dyberg; Cecilia Krona; Edward Visse; Helena Carén; Paul A Northcott; Marcel Kool; Nils Ståhl; Annette Persson; Elisabet Englund; John I Johnsen; Peter Siesjö; Anna Darabi
Journal:  J Neurooncol       Date:  2015-03-29       Impact factor: 4.130

6.  Engineered Breast Cancer Cell Spheroids Reproduce Biologic Properties of Solid Tumors.

Authors:  Stephanie L Ham; Ramila Joshi; Gary D Luker; Hossein Tavana
Journal:  Adv Healthc Mater       Date:  2016-09-07       Impact factor: 9.933

Review 7.  Cancer stem cells: a systems biology view of their role in prognosis and therapy.

Authors:  Susan D Mertins
Journal:  Anticancer Drugs       Date:  2014-04       Impact factor: 2.248

8.  Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer.

Authors:  Diana C Marquez-Garban; Vei Mah; Mohammad Alavi; Erin L Maresh; Hsiao-Wang Chen; Lora Bagryanova; Steve Horvath; David Chia; Edward Garon; Lee Goodglick; Richard J Pietras
Journal:  Steroids       Date:  2011-05-08       Impact factor: 2.668

Review 9.  Technologies for deriving primary tumor cells for use in personalized cancer therapy.

Authors:  Abhisek Mitra; Lopa Mishra; Shulin Li
Journal:  Trends Biotechnol       Date:  2013-04-16       Impact factor: 19.536

Review 10.  Using drug response data to identify molecular effectors, and molecular "omic" data to identify candidate drugs in cancer.

Authors:  William C Reinhold; Sudhir Varma; Vinodh N Rajapakse; Augustin Luna; Fabricio Garmus Sousa; Kurt W Kohn; Yves G Pommier
Journal:  Hum Genet       Date:  2014-09-12       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.